IRCT20180515039672N3已完成4 期
The Phase IV study for assessment of the onset of action and Treatment EmergentAdverse Events of Dyston (Botulinum Toxin Type A- ImenVaccine Co.) in Glabellar Lines Improvement
Imen Vaccine Alborz0 个研究点目标入组 184 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 184
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •18 to 75 year old volunteer
- •Moderate to severe glabellar lines at maximum frown
- •Signed an informed consent form
- •Being agree with 14-day follow up
排除标准
- •Hypersensitivity to botulinum toxin or any other ingredients in the formulation
- •Taking the following medicines: aminoglycosides, penicillamine, quinine, chloroquine, hydroxychloroquine, calcium channel blockers, Anticoagulants (warfarin and aspirin)
- •Any aesthetic surgery (e.g. fillers injection, chemical peeling, laser) or any other materials causing remodeling of the skin or active changes in the glabellar area within the last 12 months
- •Previous history of any surgery in the facial muscles or scars in the glabellar area and the surrounding areas (including eyebrows)
- •The medical condition that may affect neuromuscular function (e.g., myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis)
- •History of facial nerve palsy
- •Marked facial asymmetry
- •History of the eyelid or eyebrow ptosis due to the facial muscle palsy
- •Any active infection or acute skin disease in the injection sites
- •Pregnant or lactating females
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate the effectiveness of aflibercept in patients with macular edema secondary to central retinal vein occlusion.Macular edema secondary to central retinal vein occlusion.EUCTR2014-000975-21-ESFundación Retinaplus +
进行中（未招募）
1 期
A Clinical Research Study for People with Relapsing Multiple SclerosisRelapsing multiple sclerosisMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-002631-42-FIMerck KGaA300
进行中（未招募）
1 期
A Clinical Research Study for People with Relapsing Multiple SclerosisRelapsing multiple sclerosisMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-002631-42-HUMerck KGaA300
进行中（未招募）
1 期
A Clinical Research Study for People with Relapsing Multiple SclerosisEUCTR2017-002631-42-ATMerck KGaA265
进行中（未招募）
1 期
A Clinical Research Study for People with Relapsing Multiple SclerosisEUCTR2017-002631-42-SEMerck KGaA265